A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab

A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab

Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gunduz, Ozge, Modi, Zateen, Modi, Deepak
Médium: Online
Jazyk:angličtina
Vydáno: International Association for Dental Research (Nigeria Division) 2019
On-line přístup:https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

Podobné jednotky